NRXP Long Put Strategy
NRXP (NRx Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.
NRXP (NRx Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $58.1M, a beta of 2.18 versus the broader market, a 52-week range of 1.62-5.055, average daily share volume of 1.2M, a public-listing history dating back to 2017, approximately 29 full-time employees. These structural characteristics shape how NRXP stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.18 indicates NRXP has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on NRXP?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
NRXP snapshot
As of August 14, 2026, spot at $3.23, ATM IV 134.20%, IV rank 35.63%, expected move 38.47%. The long put on NRXP below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on NRXP specifically: NRXP IV at 134.20% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 38.47% (roughly $1.24 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NRXP expiries trade a higher absolute premium for lower per-day decay. Position sizing on NRXP should anchor to the underlying notional of $3.23 per share and to the trader's directional view on NRXP stock.
NRXP long put setup
The NRXP long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NRXP at $3.23 on that close, the first option leg uses a $3.23 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NRXP chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NRXP shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $3.23 | N/A |
NRXP long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
NRXP long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on NRXP. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on NRXP
Long puts on NRXP hedge an existing long NRXP stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NRXP exposure being hedged.
NRXP thesis for this long put
The market-implied 1-standard-deviation range for NRXP extends from approximately $1.99 on the downside to $4.47 on the upside. A NRXP long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long NRXP position with one put per 100 shares held. Current NRXP IV rank near 35.63% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on NRXP should anchor more to the directional view and the expected-move geometry. As a Healthcare name, NRXP options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NRXP-specific events.
NRXP long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NRXP positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NRXP alongside the broader basket even when NRXP-specific fundamentals are unchanged. Long-premium structures like a long put on NRXP are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current NRXP chain quotes before placing a trade.
Frequently asked questions
- What is a long put on NRXP?
- A long put on NRXP is the long put strategy applied to NRXP (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With NRXP stock at $3.23 on the most recent close, the strikes shown on this page are snapped to the nearest listed NRXP chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are NRXP long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the NRXP long put priced from the end-of-day chain at a 30-day expiry (ATM IV 134.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NRXP long put?
- The breakeven for the NRXP long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NRXP market-implied 1-standard-deviation expected move in the same options snapshot is approximately 38.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on NRXP?
- Long puts on NRXP hedge an existing long NRXP stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NRXP exposure being hedged.
- How does current NRXP implied volatility affect this long put?
- NRXP ATM IV is at 134.20% with IV rank near 35.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.